GSK partners with Flagship startup to hunt for Parkinson’s drugs

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for Parkinson’s and another neurodegenerative condition.

Gwendolyn Wu Member since October 20, 2023

Loading + Follow Following